Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)

CUSIP: 09627Y109

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
65,000,000
Total 13F shares
23,164,184
Share change
+23,121,596
Total reported value
$611,154,430
Price per share
$26.49
Number of holders
70
Value change
+$610,026,412
Number of buys
69

Quarterly Holders Quick Answers

What is CUSIP 09627Y109?
CUSIP 09627Y109 identifies BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q2 2015

As of 30 Jun 2015, Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,164,184 shares. The largest 10 holders included Third Rock Ventures, LLC, FMR LLC, BVF INC/IL, WELLINGTON MANAGEMENT GROUP LLP, Visium Asset Management, LP, RA CAPITAL MANAGEMENT, LLC, Partner Fund Management, L.P., LORD, ABBETT & CO. LLC, Citadel Advisors LLC, and DRIEHAUS CAPITAL MANAGEMENT LLC. This page lists 70 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.